Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Millennial heresy

    Project Inform Perspective
    |May 29, 2003
    PubMed
    Summary
    This summary is machine-generated.

    Protease inhibitors and combination therapy transformed HIV treatment in 1996. However, four years of use reveal limitations, prompting a reevaluation of established HIV therapy beliefs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same journal

    Everything antiretroviral: 5th IAS conference, Cape Town, South Africa.

    Project Inform perspective·2012
    Same journal

    Well implemented, President Obama's national HIV/AIDS strategy is precisely what is needed to further control HIV/AIDS.

    Project Inform perspective·2011
    Same journal

    Finding health care; preparing for the future.

    Project Inform perspective·2011
    Same journal

    Protecting people with HIV in the California budget.

    Project Inform perspective·2010
    Same journal

    Current drugs in clinical study.

    Project Inform perspective·2010
    Same journal

    HIV treatment information.

    Project Inform perspective·2010
    See all related articles

    Area of Science:

    • Infectious Diseases
    • Virology
    • Pharmacology

    Background:

    • The introduction of protease inhibitors and three-drug combination therapy in 1996 marked a paradigm shift in human immunodeficiency virus (HIV) management.
    • This aggressive treatment standard rapidly became widespread, particularly in developed nations, offering unprecedented therapeutic advancements.

    Discussion:

    • Four years of clinical experience with these novel HIV therapies have exposed certain challenges and potential drawbacks.
    • These emerging issues necessitate a critical review of the initial assumptions and widespread adoption of the aggressive treatment protocols.

    Key Insights:

    • The initial success of protease inhibitors and combination therapy in HIV treatment is undeniable.
    • However, long-term efficacy and potential adverse effects warrant a nuanced understanding beyond the initial revolutionary impact.

    Related Experiment Videos

    Outlook:

    • Further research is crucial to address the identified limitations and refine current HIV treatment strategies.
    • Revisiting established beliefs about HIV therapy is essential for optimizing patient outcomes and developing more sustainable treatment regimens.